Wipro Positioned as 'Leader' in Everest Group Life Sciences Operations PEAK Matrix® Assessment 2022

Everest Group presented a detailed assessment of 32 operations service providers featured on the Life Sciences Operations – Services PEAK Matrix®.

“In 2021, the life sciences industry witnessed an increased focus on safety, a transition to an omnichannel approach for patient interactions, and an expedited reliance on digital tools and technologies. These changes opened new growth avenues and prompted enterprises to seek external support to serve the evolving market better,” said Abhishek AK, Practice Director at Everest Group. “Wipro’s continuous focus on enhancing its technological offerings and expansion of its life sciences operations FTEs helped the firm achieve high revenue growth and positioned it as a Leader on Everest Group’s Life Sciences Operations PEAK Matrix® Assessment 2022.”

Everest Group has called out a few of Wipro’s key strengths:

• Wipro has experienced a high double-digit revenue and client growth in 2021 and has many FTEs in its life sciences operations.
•  Wipro, through its platform solutions such as Talosafe and Harmony, covers the entire life sciences value chain from clinical trials, supply chain, commercial operations, PV, regulatory affairs, and quality.
•  Wipro has a diversified client portfolio with a heavy mix of biopharma and medical devices.
• The company continues to enhance its technology and services portfolio via in-house investments (launched automation PV solution – Talosafe), inorganic routes such as managed services engagements (Regulatory Literature Monitoring Services from Springer Nature), and partnerships (including Compliance Quest for quality management and Ontotext for literature search)
• Clients highlight its faster TAT, responsiveness, and flexibility as areas of key strengths.